FUSAROLI, MICHELE

FUSAROLI, MICHELE  

DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Dottorandi  

Mostra records
Risultati 1 - 20 di 48 (tempo di esecuzione: 0.053 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency Giunchi, Valentina; Fusaroli, Michele; Cangini, Agnese; Fortinguerra, Filomena; Zito, Simona; Pie...rantozzi, Andrea; Lunghi, Carlotta; Poluzzi, Elisabetta; Trotta, Francesco 2025-01-01 BJCP. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista Brit J Clinical Pharma - 2025 - Giunchi - Assessing the environmental impact of medicines in Italy using data from the.pdf
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System Cecco, S.; Puligheddu, S.; Fusaroli, M.; Gerratana, L.; Yan, M.; Zamagni, C.; De Ponti, F.; Rasch...i, E. 2024-01-01 TARGETED ONCOLOGY - 1.01 Articolo in rivista -
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-023-01391-4.pdf40264_2023_1391_MOESM1_ESM.docx
Environmental sustainability-an essential component of rational use of medicines Giunchi, V; Fusaroli, M; Linder, E; Villén, J; Raschi, E; Lunghi, C; Wettermark, B; Poluzzi, E; N...ekoro, M 2024-01-01 INTERNATIONAL JOURNAL OF PHARMACY PRACTICE - 1.01 Articolo in rivista -
Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports A Note of Caution Fusaroli, M.; Khouri, C.; Poluzzi, E.; De Ponti, F.; Salvo, F.; Raschi, E. 2024-01-01 JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY - 1.01 Articolo in rivista -
Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase Noseda, R.; Bedussi, F.; Giunchi, V.; Fusaroli, M.; Raschi, E.; Ceschi, A. 2024-01-01 JOURNAL FOR IMMUNOTHERAPY OF CANCER - 1.01 Articolo in rivista e009902.full.pdf
The evolving role of disproportionality analysis in pharmacovigilance Fusaroli, M.; Raschi, E.; Poluzzi, E.; Hauben, M. 2024-01-01 EXPERT OPINION ON DRUG SAFETY - 1.01 Articolo in rivista -
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Can...dore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-024-01421-9.pdf40264_2024_1421_MOESM1_ESM.pdf
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Can...dore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-024-01423-7 (1).pdf
The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline Fusaroli, M.; Salvo, F.; Khouri, C.; Raschi, E. 2024-01-01 FRONTIERS IN PHARMACOLOGY - 1.01 Articolo in rivista fphar-15-1488725.pdfData Sheet 1.PDF
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System Fusaroli, M.; Polizzi, S.; Menestrina, L.; Giunchi, V.; Pellegrini, L.; Raschi, E.; Weintraub, D....; Recanatini, M.; Castellani, G.; De Ponti, F.; Poluzzi, E. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-024-01471-z.pdf40264_2024_1471_MOESM1_ESM.pdf
Assessment of Reported Adverse Events After Interchanging Between TNF-α Inhibitor Biosimilars in the WHO Pharmacovigilance Database Pauline O.; Robert M.; Bernardeau C.; Hlavaty A.; Fusaroli M.; Roustit M.; Cracowski J.L.; Khouri C. 2023-01-01 BIODRUGS - 1.01 Articolo in rivista -
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct Fusaroli M.; Pellegrini L.; Fusaroli R.; Raschi E.; Menchetti M.; Poluzzi E. 2023-01-01 ADDICTION - 1.01 Articolo in rivista Behavioral excess and disruptive conduct A historical and taxonomic approach to the origin of the 'impulse control disorders' diagnostic construct.pdf
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, ...Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco 2023-01-01 JTO CLINICAL AND RESEARCH REPORTS - 1.01 Articolo in rivista Sisi et al. JTO CCR 23.pdfSisi et al. JTO CCR supplementary 23.pdf
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians Raschi, Emanuel; Rossi, Simone; De Giglio, Andrea; Fusaroli, Michele; Burgazzi, Flavio; Rinaldi, ...Rita; Potena, Luciano 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista Raschi et al., Drug Safety Cardiotoxicity ICI 2023.pdf40264_2023_1320_MOESM1_ESM.pdf
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista -
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Pont...i F.; Pelotti S.; Poluzzi E. 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-022-01269-x.pdf40264_2022_1269_MOESM1_ESM.pdf
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M....; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E. 2023-01-01 PSYCHIATRY AND CLINICAL NEUROSCIENCES - 1.01 Articolo in rivista Exploring the underlying mechanisms of drug-induced impulse control disorders a pharmacovigilance-pharmacodynamic study.pdf
Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System Fusaroli M.; Simonsen A.; Borrie S.A.; Low D.M.; Parola A.; Raschi E.; Poluzzi E.; Fusaroli R. 2023-01-01 JOURNAL OF SPEECH, LANGUAGE, AND HEARING RESEARCH - 1.01 Articolo in rivista 2022.09.05.22279609v3.full.pdf
Interpretation of Pharmacovigilance Disproportionality Analyses Khouri, Charles; Fusaroli, Michele; Salvo, Francesco; Raschi, Emanuel 2023-01-01 CLINICAL PHARMACOLOGY & THERAPEUTICS - 1.04 Replica / breve intervento (e simili) -